Elena Splendiani

Pubblicazioni

Titolo Pubblicato in Anno
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers? PHARMACOLOGY & THERAPEUTICS 2024
Open-ST: High-resolution spatial transcriptomics in 3D CELL 2024
Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer EUROPEAN UROLOGY ONCOLOGY 2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study SCIENTIFIC REPORTS 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value BIOMARKER RESEARCH 2023
Low molecular weight heparin -induced miRNA changes in peripheral blood mononuclear cells in pregnancies with unexplained recurrent pregnancy loss JOURNAL OF REPRODUCTIVE IMMUNOLOGY 2022
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
{MEDB}-09. Unraveling the role of unfolded protein response in medulloblastoma cancer stem cells NEURO-ONCOLOGY 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression BIOMARKER RESEARCH 2022
A novel microRNA signature for the detection of melanoma by liquid biopsy JOURNAL OF TRANSLATIONAL MEDICINE 2022
Network analysis integrating microRNA expression profiling with MRI biomarkers and clinical data for prostate cancer early detection: a proof of concept study BIOMEDICINES 2021
Chlamydia trachomatis elicits TLR3 expression but disrupts the inflammatory signaling down-modulating NFκB and IRF3 transcription factors in human Sertoli cells JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS 2020

ERC

  • LS2_3
  • LS2_4
  • LS3_3
  • LS3_5
  • LS3_12
  • LS4_12
  • LS5_4

KET

  • Nanotecnologie
  • Life-science technologies & biotechnologies

Keywords

miRNAs
brain cancer
prostate cancer
malignant melanoma
Diabetes Mellitus

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma